ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Outcomes of Extracorporeal Membrane Oxygenation in Patients with Severe Acute Respiratory Distress Syndrome Caused by COVID-19 Versus Influenza

Friday, April 29, 2022

Submitted by

Christopher Anderson

Source

Source Name: The Annals of Thoracic Surgery

Source URL: https://doi.org/10.1016/j.athoracsur.2021.05.060

Author(s)

Emily Shih, MD John J. Squiers, MD J. Michael DiMaio, MD Timothy George, MD Jasjit Banwait, PhD Kara Monday, MD Britton Blough, MD Dan Meyer, MD Gary S. Schwartz, MD

Extracorporeal membrane oxygenation (ECMO) can be effective for refractory acute respiratory distress syndrome (ARDS) in patients with influenza, but its utility in patients with coronavirus disease 2019 (COVID-19) is uncertain. We compared outcomes of patients with refractory ARDS from COVID-19 and influenza placed on ECMO.